Low dose melphalan in the treatment of myelofibrosis: a single centre experience.
Chee
L
L
Kalnins
R
R
Turner
P
P
D000368:Aged; D000369:Aged, 80 and over; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008558:Melphalan / Q000627:therapeutic use*; D008875:Middle Aged; D010641:Phenotype; D055728:Primary Myelofibrosis / Q000097:blood / Q000188:drug therapy*; D011379:Prognosis; D013997:Time Factors; D016896:Treatment Outcome
D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan